Fundamentals

Valuation

Metric	Q1	Q2	Δ in %
EV/EBITDA	-94.66	83.14	-1556.28
Graham Fair Price	-27.02	1.65	2.25
PEG	1580.28	-0.78	0.05
Price/Book	-4.44	1.06	1.11
Price/Cash Flow	-32.92	-13.89	-10.45
Prices/Earnings	78.71	36.52	20.44
Price/Sales	-39.76	21.50	35.68
Price/FCF	-32.92	-13.89	-10.45
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q1	Q2	Δ in %
Gross Profit Margin	128.78	0.53	0.23
Operating Margin	-66.27	0.18	0.54
ROA	-44.82	< 0.005	< 0.005
ROE	0.01	< 0.005	-46.53
ROIC	< 0.005	< 0.005	-45.24
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q1	Q2	Δ in %
Debt QOQ	-0.50	0.93	-46.43
Dividends QOQ	-0.25	0.94	282.82
EBIT QOQ	4.79	-0.47	-90.26
EPS QOQ	4.38	-0.47	-89.36
FCF QOQ	-1.57	0.28	-82.04
Revenue QOQ	-0.37	0.58	57.70
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q1	Q2	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	3851.05	3655.14	-5.09
Days Sales Outstanding (DSO)	1917.10	136.89	-92.86
Inventory Turnover	0.02	0.02	5.36
Debt/Capitalization	0.76	0.77	1.08
Quick Ratio	335.20	2.58	-99.23
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q1	Q2	Δ in %
Book Value	4.08	5.20	27.56
Cash	1.29	7.84	509.14
Capex	< 0.005	< 0.005	-31.62
Free Cash Flow	-0.43	-0.31	28.25
Revenue	0.13	0.20	58.29
Naive Interpretation	member

05 - Per Share Metrics · Best

Fundamentals

Financial Health

Metric	Q1	Q2	Δ in %
Current Ratio	350.07	4.86	-98.61
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-1123.81	-34.78	96.90
Naive Interpretation	Member

06 - Financial Health · Bad

Rating